The Challenge of Change - Managing Excipients Control
Colorcon
08-Sep-2010 - Global biopharmaceutical company, Bristol-Myers Squibb will buy ZymoGenetics for $885m to become owner of a hepatitis C drug the companies are jointly developing.
07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.
06-Sep-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Inspire, King, Bionor and Oncothyreon.
02-Sep-2010 - Ranbaxy is latest firm targeting South African growth with a new £30m (€24m) Johannesburg tablet and capsule manufacturing plant.
01-Sep-2010 - Tracking “non-content” metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber.
31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”
30-Aug-2010 - ZRG Partners says there was a “fight for talent” in hiring, firing and vacancies in Q2, with the outsourcing and pharmaceutical sectors battling for employees within regulatory, quality and clinical roles.
30-Aug-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Labs, NewAge Industries and Jennerex.
30-Aug-2010 - Sanofi Aventis has gone public with its $18.5bn (€14.5bn) takeover bid for US biotech Genzyme, putting more pressure on firm’s “unwilling” board
23-Aug-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including J&J strengthening manufacturing and appointments at Alexza and Inspire.
19-Aug-2010 - Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
18-Aug-2010 - Imclone has closed the manufacturing facility in Branchburg, New Jersey where it produces the cancer drug Erbitux, according to reports in the US media.
16-Aug-2010 - Australia-based Sigma has agreed to sell its pharmaceutical division to Aspen for A$900m (US$802m).
16-Aug-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Ranbaxy’s CEO stepping down and appointments at Avid, the USP and Novavax.
12-Aug-2010 - Furiex posts Q2 loss as increased R&D spending and higher admin costs offset revenue gains, but firm is confident development model can boost partners’ pipelines.
09-Aug-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Watson Pharmaceuticals, Shire, Lupin and AmerisourceBergen.
04-Aug-2010 - In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how it can benefit drugmakers.
03-Aug-2010 - Calls for US government to break Genzyme’s Fabrazyme patents accompany more speculation that French drugmaker Sanofi Aventis is in takeover talks.
02-Aug-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Roche, Caraco, CMP Therapeutics and Unilife.
02-Aug-2010 - From today, you can access in-Pharmatechnologist.com from your mobile phone.
29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact on contract research organizations (CRO).
27-Jul-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Phage Pharmaceuticals, the USP and Nycomed.
26-Jul-2010 - Medical Technology group Becton Dickson (BD) will build a $38m warehouse facility in Four Oaks, North Carolina, according to State Governor Bev Perdue.
26-Jul-2010 - European drugmakers Sanofi-Aventis and GlaxoSmithKline (GSK) are rumoured to be looking at a possible acquisition of US biotechnology group Genzyme.
20-Jul-2010 - A group of Irish drug firms and banks plan to set up a “global pharmaceutical centre of excellence” (COE) that they believe will create 4,800 research, development and manufacturing jobs.